Medical College of Wisconsin
CTSICores SearchResearch InformaticsREDCap

Lynn M. Malec MD

Lynn M. Malec MD profile photo picture

Assistant Professor

Institution: Medical College of Wisconsin
Department: Medicine
Division: Hematology and Oncology - Medicine
Program: Hematology


Publications (12)

  • Regional variation and cost implications of prescribed extended half-life factor concentrates among U.S. Haemophilia Treatment Centres for patients with moderate and severe haemophilia. (Croteau SE, Cheng D, Cohen AJ, Holmes CE, Malec LM, Silvey M, Thornburg CD, Wheeler AP, Kouides PA, Raffini LJ, Neufeld EJ) Haemophilia 2019 Jul;25(4):668-675 PMID: 30993845 04/18/2019       6 Citations
  • Prophylactic rtPA in the Prevention of Line-associated Thrombosis and Infection in Short Bowel Syndrome. (Malec LM, Cooper J, Rudolph J, Michaels MG, Ragni MV) J Pediatr Gastroenterol Nutr 2018 Jun;66(6):972-975 PMID: 29135819 11/15/2017       2 Citations
  • Feasibility of the Von Willebrand disease PREVENT trial. (Ragni MV, Machin N, James AH, Seaman CD, Malec LM, Kessler CM, Konkle BA, Kouides PA, Neff AT, Philipp CS, Brooks MM) Thromb Res 2017 Aug;156:8-13 PMID: 28577390 06/04/2017       5 Citations
  • Venous thromboembolism in pediatric trauma patients: Ten-year experience and long-term follow-up in a tertiary care center. (Leeper CM, Vissa M, Cooper JD, Malec LM, Gaines BA) Pediatr Blood Cancer 2017 Aug;64(8) PMID: 28067012 01/10/2017       12 Citations
  • Extended half-life factor VIII for immune tolerance induction in haemophilia. (Malec LM, Journeycake J, Ragni MV) Haemophilia 2016 Nov;22(6):e552-e554 PMID: 27640873 09/20/2016       17 Citations
  • Inhibitor development in two cousins receiving full-length factor VIII (FVIII) and FVIII-Fc fusion protein. (Ragni MV, Alabek M, Malec LM) Haemophilia 2016 Sep;22(5):e462-4 PMID: 27501368 08/09/2016       6 Citations
  • Von Willebrand factor for menorrhagia: a survey and literature review. (Ragni MV, Machin N, Malec LM, James AH, Kessler CM, Konkle BA, Kouides PA, Neff AT, Philipp CS, Brambilla DJ) Haemophilia 2016 May;22(3):397-402 PMID: 26843404 PMCID: PMC4874860 02/05/2016       19 Citations
  • Validation Study of the Composite Score to Identify Von Willebrand Disease in Children. (Malec LM, Moore CG, Bennett CM, Yee DL, Kerlin BA, Witmer CM, Kulkarni R, Gupta S, Gunawardena S, Kouides PA, Brown D, Ragni MV) J Pediatr Hematol Oncol 2016 Mar;38(2):139-42 PMID: 26535774 11/05/2015       5 Citations
  • Thrombin generation and bleeding in haemophilia inhibitor patients during immune tolerance induction. (Ragni MV, DiMichele DM, Hay CM, Malec LM, Seaman CD, Li J, Yabes JG, Butenas S, Brummel-Ziedins K) Haemophilia 2016 Mar;22(2):240-247 PMID: 26517283 10/31/2015    
  • Postpartum haemorrhage in women with von Willebrand disease: an observational study of the Pennsylvania Health Care Cost Containment Council (PHC4) database. (Malec LM, Moore CG, Yabes J, Li J, Ragni MV) Haemophilia 2015 Sep;21(5):e442-5 PMID: 26189327 07/21/2015       7 Citations
  • Design of the INHIBIT trial: preventing inhibitors by avoiding 'danger', prolonging half-life and promoting tolerance. (Ragni MV, Malec LM) Expert Rev Hematol 2014 Dec;7(6):747-55 PMID: 25374055 PMCID: PMC4356531 11/07/2014       13 Citations
  • Three cost-utility analyses of screening for intracranial hemorrhage in neonates with hemophilia. (Malec LM, Sidonio RF Jr, Smith KJ, Cooper JD) J Pediatr Hematol Oncol 2014 Aug;36(6):474-9 PMID: 25054457 07/24/2014       3 Citations
  • Last update: 10/06/2019
    jenkins-FCD Prod-480 9a4deaf152b0b06dd18151814fff2e18f6c05280